Yüklüyor......
Is metastatic pancreatic cancer an untargetable malignancy?
Metastatic pancreatic cancer (MPC) is one of the most aggressive malignancies, known to be chemo-resistant and have been recently considered resistant to some targeted therapies (TT). Erlotinib combined to gemcitabine is the only targeted therapy that showed an overall survival benefit in MPC. New t...
Kaydedildi:
| Yayımlandı: | World J Gastrointest Oncol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4789615/ https://ncbi.nlm.nih.gov/pubmed/26989465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i3.297 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|